INHIBITION OF CALCIUM-DEPENDENT REGULATOR-STIMULATED PHOSPHODIESTERASE ACTIVITY BY NEUROLEPTIC DRUGS IS UNRELATED TO THEIR CLINICAL EFFICACY

This publication has 12 references indexed in Scilit:

• Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1978
• Modulator protein as a component of the myosin light chain kinase from chicken gizzard
  Biochemistry, 1978
• Physicochemical properties of rat testis Ca2+-dependent regulator protein of cyclic nucleotide phosphodiesterase. Relationship of Ca2+-binding, conformational changes, and phosphodiesterase activity
  Journal of Biological Chemistry, 1977
• Anti-schizophrenic drugs—Membrane receptor sites of action
  Biochemical Pharmacology, 1977
• BINDING OF TRIFLUOPERAZINE TO CALCIUM-DEPENDENT ACTIVATOR OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE
  1977
• Regulation of adenylate cyclase from glial tumor cells by calcium and a calcium-binding protein.
  Journal of Biological Chemistry, 1976
• Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity
  Canadian Journal of Physiology and Pharmacology, 1976
• A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
  Analytical Biochemistry, 1976
• MECHANISM BY WHICH PSYCHOTROPIC-DRUGS INHIBIT ADENOSINE CYCLIC 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE OF BRAIN
  1976
• Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum
  Journal of Pharmacy and Pharmacology, 1975